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Abstract
Background: A randomized, double-blind, controlled clinical trial was conducted to evaluate the effectiveness
of a propolis rinse on induced gingivitis by using the co-twin study design.
Methods: Twenty-one twin pairs (n= 42) were enrolled in a gingivitis study with oral hygiene promotion (14
days) and gingivitis induction (21 days). During the gingivitis induction phase, one member of the twin pair was
randomly assigned to a 2% typified propolis rinse, and the other was assigned a color-matched 0.05% sodium
fluoride plus 0.05% cetylpyridinium chloride rinse (positive control). Patients rinsed twice daily with 20mL for 30
seconds for 21 days. Gingivitis was measured on days - 14 (baseline), 0 (after hygiene phase), and 21 (after no-
hygiene phase) by using the Papillary Bleeding Score (PBS) and by standard digital imaging of the gum tissues
(G-parameter).
Results: The 38 persons who completed the study (age 13–22 years) were well balanced according to PBS at
baseline and G-parameter after the initial hygiene phase. After 21 days without oral hygiene, the propolis rinse
and positive control rinse groups did not differ significantly for average PBS measurements or G-parameter.
Conclusions: Use of a 2% typified propolis rinse was equivalent to a positive control rinse during a 21-day no-
hygiene period.
Introduction
The high prevalence of gingivitis in a representativesample of U.S. adults (range, 56%–94%)1 highlights the
fact that current preventive strategies have not been effective
on gingivitis from a population standpoint. Therefore, re-
newed efforts for the development of new preventive strat-
egies are necessary.
Propolis is a resinous matter collected by honeybees from
different plant exudates that is used to seal beehives. Propolis
possesses distinct biological activities, such as antibacterial,
antiviral, fungicidal, anti-inflammatory, antitumor, and wound-
healing properties.2–4 At least 200 compounds have been
identified in different propolis samples of different botanical
geographic origins, which may include fatty and phenolic acids
and esters, substituted phenolic esters, flavonoids, terpenes, b-
steroids, aromatic aldehydes, alcohols, sesquiterpenes, naph-
thalene, and stilbene derivatives.4–7
Propolis use dates back to about 300 BCE, when it was first
used for cosmetics and as a therapeutic medicine.4 Accord-
ingly, propolis has been used in folk medicine since ancient
times and is now widely used empirically worldwide. The
literature on propolis use and its many attributes in dentistry is
extensive. In the oropharyngeal domain, numerous laboratory
and clinical reports describe use of propolis against cariogenic
organisms,8 periodontal organisms,9 respiratory infections,10
gingival inflammation,11 endodontic pathogens,12 and oral
ulcers,13 among other oral conditions. These reports, however,
lack evidence on the effectiveness of propolis because ade-
quately designed randomized controlled trials have yet to be
conducted. Conversely, double-blind, randomized, controlled
design trials have shown that mouthwashes containing sodium
fluoride (NaF) plus cetylpyridinium chloride (CPF) controlled
supragingival plaque accumulation.14
The experimental (i.e., induced) gingivitis model has
been used extensively to evaluate the potential clinical ef-
ficacy of both dentifrices and mouth rinses containing an-
timicrobial agents to assess treatment responses.15–19
The aim of this study was to assess the effectiveness of
a 2% typified propolis rinse on induced gingivitis in a
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single-center, double-blind, randomized, parallel clinical
trial.
Materials and Methods
Inclusion/exclusion criteria
Inclusion criteria were (1) age least 13 years; (2) provision
of written informed consent; (3) presence of all 12 anterior
teeth without caries lesions or restorations; and (4) general
good health. Exclusion criteria were (1) severe periodontal
disease, as characterized by purulent exudates, generalized
mobility, and/or severe recession; (2) any condition that re-
quires antibiotic premedication for the administration of a
dental prophylaxis; (3) self-reported pregnancy, intent to
become pregnant during the study, or breast-feeding; (4)
atypical discoloration or pigmentation in the gingival tissue;
(5) fixed orthodontic appliances; (6) any diseases or condi-
tions that could be expected to interfere with safe completion
of the study; and (7) history of antibiotic use in the previous
3 months.
Study design/demographic characteristics
This study compared a 2% typified propolis rinse with an
NaF plus CPC rinse (positive control). Thirty twin pairs
were initially screened for eligibility criteria. Nine twin pairs
were ineligible because of anterior carious lesions (four twin
pairs) and the use of fixed orthodontic appliances (five twins
pairs). Twenty-one eligible twin pairs 13–22 years of age
signed consent forms and were enrolled into the study.
Nineteen evaluable twin pairs completed the study proto-
cols. Two twin pairs were withdrawn from the study because
one twin member did not adhere to study protocols. Recruit-
ment and follow-up visits took place between March and
August 2008. Table 1 depicts age, sex, and zygosity before
commencement of the trial, which were well balanced be-
tween study groups.
After a run-in brushing period (hygiene phase), partici-
pants were asked to abstain from tooth brushing and flossing
(induced gingivitis) while undergoing twice-daily assigned
rinsing. Safety and effectiveness were evaluated weekly
over 3 weeks during gingivitis induction, which was fol-
lowed by prophylaxis to regain relative gingival health. The
institutional ethics board independently reviewed and ap-
proved the research protocol.
Allocation concealment
We used a computer-generated list of random numbers to
allocate groups. Rinses were prepared in dark bottles, which
were consecutively numbered according to the randomiza-
tion schedule. Twins were randomly assigned to one of the
two test color-matched rinses. The study coordinator, ex-
aminers, and participants were unaware of group allocation.
The group identity was generated and maintained in the
United States, and the study was conducted in Brazil.
Study protocol
Oral hygiene phase (day -14 to day 0). The medical
history of participants was obtained and an oral soft tissue
examination was performed, followed by assessment of
gingival status according to the Papillary Bleeding Score
(PBS)20 and color digital imaging of the gums. After re-
ceiving dental prophylaxis, participants were instructed to
return to the site once a day. At that time they brushed under
supervision using a battery-powered toothbrush for 2 min-
utes with a marketed anticavity dentifrice. The second
brushing for the day was performed without supervision.
This brushing regimen was followed for the next 14 days.
Day 0 is the conclusion of the oral hygiene phase and the
baseline visit for the induced-gingivitis phase.
Induced-gingivitis phase (day 0–day 21). During this
phase, participants were instructed to abstain from all forms
of oral hygiene except the administered mouth rinse. Parti-
cipants returned to the study site once a day (after a meal), at
which time they rinsed (with 25mL for 30 seconds) under
supervision with their assigned product. A second rinse was
performed at home without supervision before sleep. This
rinsing regimen was followed for the next 21 days and digital
images of anterior teeth and a PBS exam were performed.
Recovery phase (also day 21 of experimental gingivitis
phase). Following the clinical examinations made on day
21 of the induced-gingivitis phase, participants were provided
Table 1. Demographic Characteristics of Study Groups
Demographic/statistic or category
Propolis
(n = 19)
Positive control
(n = 19)
Overall
(n = 38)
Two-sided
p-value
Age (yr)
Mean (SD) 16.1 (2.59) 16.1 (2.59) 16.1 (2.56) 1.000a
Minimum, median, maximum 13, 15, 22 13, 15, 22 13, 15, 22
Sex, n (%)
Female 11 (58) 11 (58) 22 (58) 1.000b
Male 8 (42) 8 (42) 16 (42)
Zygosity, n (%)
Dizygotic 12 (63) 12 (63) 24 (63) 1.000b
Monozygotic 7 (37) 7 (37) 14 (37)
aTwo-sided analysis of variance p-value for the treatment comparison.
bTwo-sided chi-square p-value for the treatment comparison.
SD, standard deviation.
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additional prophylaxis and were monitored thereafter until
deemed healthy.
Gingival parameters/primary outcomes
Red-green-blue digital imaging. This system consists of
an S2 Pro CCD high-resolution digital color camera (Fuji,
Minato, Japan) equipped with a Nikon Micro Nikkor lens
(Nikon, Tokyo, Japan) with a linear polarizer to permit
cross-polarized light. Gingivitis image analysis used anterior
facial images collected with cheek retractors and standard-
ized digital photography and lighting. Red-green-blue val-
ues were assessed on the marginal gingiva by using image
analysis software, with change in G parameter (redness) as
the primary response parameter. Paired images were com-
pared to assess longitudinal responses. This noninvasive
objective imaging system provides information that is
highly correlated with gingivitis clinical measurements.21
Papillary Bleeding Score. After imagery, PBS measure-
ments were made on the mesial buccal surfaces of all teeth,
excluding the third molars. To obtain this index, a triangle-
shaped toothpick (Stim-U-Dent, Johnson & Johnson, New
Brunswick, New Jersey) made of soft, pliable wood is used
to stimulate the interproximal papilla. The test was per-
formed by doing one quadrant at a time. The Stim-U-Dent
device is inserted horizontally between the teeth from the
facial surface, depressing the interproximal papilla by up to
2mm. It was inserted once, and then the site was scored
after 15 seconds. PBS values ranged from 0 (healthy gin-
giva) to 5 (severe inflammation, marked redness and edema,
and tendency to spontaneous bleeding). The PBS has been
reported to be the most reproducible and reliable index (both
within and between examiners) for measuring the gingival
status of patients compared with established indices for
gingivitis.22 PBS was measured by an experienced examiner
(ALM). Intra-examiner reliability exercises revealed a jtest
score of 0.85, indicating adequate reproducibility of PBS
measurements.
Safety/adverse reactions
Oral soft tissues were assessed by visual examination of
the oral cavity. The structures examined include the gingiva
(free and attached), hard and soft palate, oropharynx/uvula,
buccal mucosa, tongue, floor of the mouth, labial mucosa,
mucobuccal/mucolabial folds, lips, and perioral area. In
addition, any reported adverse reaction to study protocols
was documented.
Rinse formulation
Propolis 2% rinse was manufactured at the laboratories of
the Department of Pharmacology at Federal University of
Santa Catarina, Floriano´polis, SC, Brazil. The formulation
included 2% typified propolis, mint flavor, polioxyethelers,
sorbitol, blue coloring, and water. Propolis rinse was made
by using green propolis (State of Minas Gerais, Brazil)
evaluated by high-performance liquid chromatography
analysis, showing high levels of the phenolic compounds (in
Table 2. Digital Imaging Gum Color (Redness [G]) for Experimental Groups During the Study Periods
Treatment Participants (n) Mean (SD) Median Minimum–maximum
Day - 14
Propolis 19 91.2 (18.74) 97.4 54.1–113.1
Positive control 19 95.4 (12.94) 98.4 59.2–111.3
Day 0
Propolis 19 95.0 (17.87) 99.3 59.2–117.7
Positive control 19 96.8 (12.61) 99.0 59.7–110.9
Day 21
Propolis 19 91.2 (16.60) 94.2 57.3–115.6
Positive control 19 94.9 (14.05) 93.8 56.0–115.9
SD, standard deviation.
Table 3. Average Whole-Mouth Papillary Bleeding Scores for Experimental
Groups During the Study Periods
Treatment Participants (n) Mean (SD) Median Minimum–maximum
Day - 14
Propolis 19 0.58 (0.415) 0.5 0.00–1.70
Positive control 19 0.48 (0.379) 0.4 0.00–1.31
Day 0
Propolis 19 0.29 (0.320) 0.2 0.00–1.12
Positive control 19 0.37 (0.437) 0.2 0.00–1.73
Day 21
Propolis 19 0.51 (0.485) 0.3 0.00–1.42
Positive control 19 0.48 (0.396) 0.3 0.00–1.42
SD, standard deviation.
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mg/g): coumaric acid (3.81), rutin (9.87), pinobanksin (3.48),
quercetin (2.15), kaempferol (0.78), apigenin (1.86), pino-
cembrin (22.55), pinobanksin-3-acetate (4.10), chrysin
(2.49), galangin (4.14), kaempferide (5.59), tectochrysin
(2.90), and artepillin C (87.97). The content of phenolic
compounds was 151.69mg of dried extract per g. The for-
mulation of the positive control rinse (Reach, Johnson &
Johnson, Sa˜o Jose´ dos Campos, SP, Brazil) contains 0.05%
NaF, 0.05% CPC, blue coloring, alcohol, and sucralose.
Statistical analysis
The co-twin study design exploits matching on many ob-
served and unobserved factors and hence provides extremely
attractive sampling units for test-control studies.23,24 This fact
forms the basis for the often-used ‘‘co-twin’’ designs in ep-
idemiology.25,26 The stronger the residual phenotypic corre-
lation between the twins (i.e., the phenotypic correlation
between the twins that is attributable to known factors), the
greater the power to detect differences (e.g., via a t-test) in the
twins’ phenotypic values, in this case gingival inflammation
outcomes. Hence, by using the co-twin study design, reduced
sample sizes can provide information that would otherwise
require larger cohorts.
The average color of gingival tissue within 1.5mm of the
gingival margin of the anterior dentition (facial surfaces) was
calculated for each participant at day - 14, day 0, and day 21
by digital imaging. A whole-mouth average PBS was calcu-
lated for each participant accordingly. Analysis of covariance
was used to allow for comparisons between study groups with
respect to average gingival redness (G parameter) and
bleeding (PBS). A separate statistical model was used to test
each hypothesis at each visit. The baseline value of each
respective endpoint was used as the covariate in each model.
A general linear mixed model was used to compare G and
PBS at day 21 between rinse groups, with day - 14, day 0,
zygosity, and age used as fixed effects and family ID as a
random effect. Data were analyzed with the SAS/STAT
software (Cary, North Carolina).
Results
The aim of this study was to assess the effectiveness of a
2% typified propolis rinse on induced gingivitis in a single-
center, double-blind, randomized, parallel clinical trial.
With the exception of one participant who reported staining
of the teeth in the propolis group, no adverse reactions related
to study procedures occurred. Tables 2 and 3 provide results
for average whole-mouth PBS values and average digital im-
aging gum color (G parameter) for the hygiene phase and for
the induced-gingivitis period. Groups were well balanced at
the beginning of the hygiene phase (day - 14) and remained so
for the start of the induced-gingivitis phase (day 0). Duration of
the induced-gingivitis phase (gingival inflammation measured
by digital imaging) and average whole-mouth PBS did not
significantly differ between groups.
In Tables 4 and 5, footnote ‘‘a’’ refers to p-values from
analysis of variance comparing group means at days 0 and 21,
which show that there are no significant differences between
groups for either gingival parameter. Footnote ‘‘b’’ refers to
paired t-tests for comparing the mean change from baseline to
zero (to see whether the incremental change was statistically
significant within each treatment group). For Tables 4 and 5,
‘‘baseline’’ refers to day - 14 for the day 0 visit and day 0 for
the day 21 visit. For the G-parameter (Table 4), no significant
changes from baseline were observed for the positive control
group at days 0 and 21. The propolis group had significant
contrasting outcomes for the G-parameter from baseline at
Table 4. Change from Baseline Digital Imaging Gum Color Redness (G)
Treatment Participants (n) Baseline mean p-Valuea Mean (SD) p-Valueb Median Minimum—maximum
Day 0
Propolis 19 91.2 0.206 3.8 (4.72) 0.003 5.1 - 4.1 to 11.5
Positive control 19 95.4 1.3 (5.16) 0.270 1.5 - 12.6 to 8.5
Day 21
Propolis 19 94.2 0.576 - 3.0 (3.84) 0.004 - 3.2 - 9.5 to 4.8
Positive control 19 96.0 - 1.1 (5.21) 0.384 - 0.3 - 11.9 to 7.1
aTwo-sided p-value for the baseline treatment comparison.
bTwo-sided paired-difference p-value.
SD, standard deviation.
Table 5. Change from Baseline for Whole-Mouth Papillary Bleeding Score
Treatment Participants (n) Baseline mean p-Valuea Mean (SD) p-Valueb Median Minimum—maximum
Day 0
Propolis 19 0.6 0.364 - 0.28 (0.425) 0.009 - 0.2 - 1.52 to 0.27
Positive control 19 0.5 - 0.11 (0.363) 0.206 - 0.1 - 0.92 to 0.42
Day 21
Propolis 19 0.3 0.542 0.20 (0.404) 0.052 0.1 - 0.65 to 1.00
Positive control 19 0.4 0.09 (0.380) 0.345 0.1 - 0.96 to 0.85
aTwo-sided p-value for the baseline treatment comparison.
bTwo-sided paired-difference p-value.
SD, standard deviation.
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days 0 and 21. Similar results were observed for average PBS
measurements (Table 5). Table 6 compares average values
for G-parameter and PBS between groups after the induced
gingivitis phase (day 21) controlling for visit, zygosity, and
age. There were no significant differences between groups for
the observed parameters.
Discussion
This clinical trial was designed as an equivalence trial.27
Equivalence trials are often used to compare a new treat-
ment with a standard therapy, although it is not possible to
determine whether two treatments have exactly equivalent
effects. In this manner, equivalence trials are designed to
show that two treatments produce effects that would be in-
distinguishable from the perspective of clinical relevance.28
Equivalence trials are often used to demonstrate that a new
product has been developed because of unique or advanta-
geous characteristics, where, for instance, the propolis rinse
can be deemed as a naturally occurring oral formulation.
In considering the above premise, it becomes clear that
the induced-gingivitis model is suitable for the conduction
of equivalence trials. This model permits assessment of the
effectiveness of oral rinses on primary outcomes related to
gingival inflammation in the absence of routine oral hygiene
procedures that are customarily performed by the general
population. It is conceivable that a protocol that would not
prevent individuals from abstaining from their daily oral
hygiene practices would have potentially shown different
results.
Our results clearly show that a 2% typified propolis rinse
was equivalent to a positive control rinse containing 0.05%
NaF and 0.05% CPC when indicators of gingival inflam-
mation were used as primary outcomes in the induced-
gingivitis model (Tables 3–6). No clinical trials have as-
sessed the effects of propolis on gingivitis. A recent phase II
study on the efficacy of a 5% typified propolis (green prop-
olis) mouthwash clearly demonstrated that twice-daily use
of the rinse for 90 days amounted to a 77% reduction in the
levels of gingival inflammation when compared with base-
line levels.11
Because of a striking variability in propolis chemical
composition based on botanical origin, it is imperative that
methods of standardization (typification) are used to de-
scribe the biologically active components present in any
formulation that contains propolis. The propolis rinse used
in this study contained propolis samples from Minas Gerais,
Brazil, that were typified and classified as BRGx29 with
markers that exhibit antimicrobial and anti-inflammatory
activity. This is crucial for comparisons between studies of
propolis formulations and their corresponding therapeutic
activities.
In conclusion, this study has demonstrated that the use of
a 2% typified propolis rinse was equivalent to a positive
control rinse during a 21-day induced-gingivitis model.
Further studies on the effects of propolis on gingivitis
should be conducted by other investigators using similar
protocols.
Acknowledgments
This study was partially supported by the National In-
stitutes of Health/National Institute of Dental and Cranio-
facial Research grant DE15351 (W.B.). Drs. Andrea Corby,
Mauricio Aquino, Mathew Barkers, and Amarilis Scremin
contributed to study protocols and analysis.
Author Disclosure Statement
No competing financial interests exist.
References
1. Li Y, Lee S, Hujoel P, et al. Prevalence and severity of
gingivitis in American adults. Am J Dent 2010;23:9–13.
2. Ghisalberti EL. Propolis: a review. Bee World 1979;60:
59v84.
3. Marcucci MC. Propolis: chemical composition, biological
properties and therapeutic activity. Apidologie 1995;26:
83–99.
4. Sforcin JM, Bankova V. Propolis: Is there a potential for the
development of new drugs? J Ethnopharmacol 2011;133:
253–260.
5. Bankova V, Christov R, Stoev G, et al. Determination of
phenolics from propolis by gas chromatography. J Chro-
matogr 1992;607:150–153.
6. Greenaway W, Scaysbrook T, Whatley FR. The analysis of
bud exudate of Populus x euramericana and propolis, by
gas chromatorgaphy-mass spectrometry. Proc R Soc Lond
Ser B 1987;232:249–272.
7. Greenaway W, May J, Scaysbrook T, et al. Identification by
gas chromatography-mass spectrometry of 150 compounds
in propolis. Z Naturforsch 1991;46C:111–121.
Table 6. Treatment Comparisons: Analysis of Covariance for Digital Imaging Gum Color
(Redness [G]) and Papillary Bleeding Scores
Treatment Comparisons
Variances
Treatment
Adjusted
mean (SEM) Versus
Estimate
(SEM)
95% Confidence
interval
Two-Sided
p-value Error Between-family
Day 21 PBS
Propolis 0.50 (0.08) Positive control - 0.54 (1.52) - 3.75 to 2.67 0.7276 12.442 17.757
Positive control 0.50 (0.08)
Day 21 gum color (G)
Propolis 91.75 (1.11) Positive control - 0.00 (0.11) - 0.23 to 0.23 0.9901 0.000 0.106
Positive control 93.29 (1.17)
SEM, standard error of the mean.
EFFECTS OF PROPOLIS ON EXPERIMENTAL GINGIVITIS 947
8. Duarte S, Rosalen PL, Hayacibara MF, et al. The influence
of a novel propolis on mutans streptococci biofilms and
caries development in rats. Arch Oral Biol 2006;51:15–22.
9. Santos FA, Bastos EM, Rodrigues PH, et al. Susceptibility
of Prevotella intermedia/Prevotella nigrescens (and Por-
phyromonas gingivalis) to propolis (bee glue) and other
antimicrobial agents. Anaerobe 2002;8:9–15.
10. Cohen HA, Varsano I, Kahan E, et al. Effectiveness of an
herbal preparation containing echinacea, propolis, and vita-
min C in preventing respiratory tract infections in children: a
randomized, double-blind, placebo-controlled, multicenter
study. Arch Pediatr Adolesc Med 2004;158:217–221.
11. Pereira EM, da Silva JL, Silva FF, et al. Clinical evidence of
the efficacy of a mouthwash containing propolis for the
control of plaque and gingivitis: aphase II study. Evid Based
Complement Altern Med 2011:750249. Epub 2011 Mar 31.
12. Moncla BJ, Guevara PW, Wallace JA, et al. The inhibitory
activity of typified propolis against Enterococcus species. Z
Naturforsch 2012;67C:249–256.
13. Samet N, Laurent C, Susarla SM, et al. The effect of bee
propolis on recurrent aphthous stomatitis: a pilot study. Clin
Oral Investig 2007;11:143–147.
14. Ayad F, Prado R, Mateo LR, et al. A comparative inves-
tigation to evaluate the clinical efficacy of an alcohol-free
CPC-containing mouthwash as compared to a control
mouthwash in controlling dental plaque and gingivitis: a
six-month clinical study on adults in San Jose, Costa Rica. J
Clin Dent 2011;22:204–212.
15. Lo¨e H, Thelaide E, Jensen SE. Experimental gingivitis in
man. J Periodontol 1965;36:1377–1387.
16. Lusk SS, Bowers GM, Tow HD. Effects of an oral rinse on
experimental gingivitis, plaque formation and formed pla-
que. J Am Soc Prev Dent 1974;4:31–33.
17. Chilton NW, Fleiss JL. Design and analysis of plaque and
gingivitis clinical trials. J Clin Periodontol 1986;13:400–410.
18. Saxton CA, van der Ouderaa FJ. The effect of a dentifrice
containing zinc citrate and Triclosan on developing gingi-
vitis. J Periodontal Res 1989;24:75–80.
19. Ramberg P, Furiichi Y, Sherl D, et al. The effect of tri-
closan on developing gingivitis. J Clin Periodontol 1995;
22:442–448.
20. Loesche WJ. Clinical and microbiological aspects of che-
motherapeutic agents used according to the specific plaque
hypothesis. J Dent Res 1979;58:2404–2412.
21. Biesbrock AR, Gibb RD, Rubush ME, et al. Concurrent
clinical and image analysis assessment of gingivitis natural
history. J Dent Res 2010;89(Spec Iss B):4742.
22. Marks RG, Magnusson I, Taylor M, et al. Evaluation of
reliability and reproducibility of dental indices. J Clin
Periodontol 1993;20:54–58.
23. Boomsma D, Busjahn A, Peltonen L. Classical twin studies
and beyond. Nat Rev Genet 2002;3:872–882.
24. MacGregor AJ, Sneider H, Schork NJ, et al. Twins. Novel
uses to study complex traits and genetic diseases. Trends
Genet 2000;16:131–134.
25. Duffy DL. Biometrical genetic analysis of the cotwin
control design. Behav Genet 1994:24:341–344.
26. Hrubec Z, Robinette CD. The study of human twins in
medical research. N Engl J Med 1984;310:435–441.
27. Lesaffre E. Superiority, equivalence, and non-inferiority
trials. Bull NYU Hosp Jt Dis 2008;66:150–154.
28. Philstrom Bl, Barnett ML. Desing, operation and interpre-
tation of clinical trials. J Dent Res 2010;89:759–772.
29. Ayres DC, Marcucci MC, Giorgio S. Effects of Brazilian
propolis on Leishmania amazonensis. Mem Inst Oswaldo
Cruz 2007;102:215–220.
Address correspondence to:
Walter. A. Bretz, DDS, PhD
Department of Cariology & Comprehensive Care
New York University College of Dentistry
345 East 24th Street
New York, NY, 10010
E-mail: wb36@nyu.edu
948 BRETZ ET AL.
This article has been cited by:
1. Laura Cornara, Marco Biagi, Jianbo Xiao, Bruno Burlando. 2017. Therapeutic Properties of Bioactive Compounds from Different
Honeybee Products. Frontiers in Pharmacology 8. . [CrossRef]
2. Karolina Wiatrak, Tadeusz Morawiec, Rafał Rój, Anna Mertas, Agnieszka Machorowska-Pieniążek, Patryk Kownacki, Marta
Tanasiewicz, Małgorzata Skucha-Nowak, Stefan Baron, Tomasz Piekarz, Maciej Wrzoł, Mateusz Bogacz, Jacek Kasperski, Iwona
Niedzielska. 2017. Oral Health of Patients Treated with Acrylic Partial Dentures Using a Toothpaste Containing Bee Product.
Evidence-Based Complementary and Alternative Medicine 2017, 1-12. [CrossRef]
